小儿门静脉高压治疗新进展

Recent advances in the treatment of portal hypertension in children

门静脉高压（portal hypertension，PH）是各种原因导致门静脉系统压力升高引起的一组临床综合征，是儿童发病率较低的严重并发症。小儿门静脉高压症的病因和治疗有别于成人。本文综合近五年小儿PH治疗的文章，总结历年国际及国内范围对该病的病案报道，分别从药物、内镜、介入、手术、肝移植等方面做了详细的描述，理清了门静脉高压治疗的最新进展，有助于提高各种病因门静脉高压患儿的治疗效果。

With a lower incidence of serious complications,portal hypertension （PH） is a group of clinical syndromes due to an elevation of portal pressure. Etiology and treatment of children with portal hypertension are different from those of adults. Published over the last five years, these articles have offered a comprehensive review of international and domestic medical case reports of PH. Medications, endoscope, interventional therapy, surgery and liver transplantation are discussed in details for improving the efficacies of various types of PH.